Annual Securities Report — FY2025
What Genky DrugStores Co.,Ltd. reported for the period from 2025-06-21 to 2026-06-20.
Filed 2026-09-09View the original on EDINET
How much it says
57Typical
What moved here
17named for the first time
Its own wording
38terms
Which filing this is
29/ 29newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the consolidated fiscal year from 21 June 2025 to 20 June 2026, the Group proceeded with new R store openings and renovations, bringing the store count to 534. Cash and cash equivalents were ¥7,866 million at period-end, while reported results included net sales of ¥220,638 million and profit attributable to owners of the parent of ¥7,875 million.
Komori's summary of this document, not the document's own words.57Typical
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
68
Detailed
94
Very detailed
88
Very detailed
0
Almost nothing
50
Typical
0
Almost nothing
55
Typical
53
Typical
79
Very detailed
73
Detailed
R&D spendNot disclosedThis document does not carry the figure.
Cash left over-33億円Cash from the business, less what went into equipment.
Spent on equipment198億円Plants, machines — things meant to last.
Employees1,973Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.